Nevada § 439B.650 Department to compile annual report concerning price of certain drugs; contents of report; presentation of report at public hearing

Nevada Statutes

§ 439B.650 — Department to compile annual report concerning price of certain drugs; contents of report; presentation of report at public hearing

Nevada § 439B.650

Title 40PUBLIC HEALTH AND SAFETY

Ch. 439BRestraining

REPORTING OF CERTAIN INFORMATION RELATING TO PRESCRIPTION DRUGS

This text of Nevada § 439B.650 (Department to compile annual report concerning price of certain drugs; contents of report; presentation of report at public hearing) is published on Counsel Stack Legal Research, covering Nevada primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Nev. Rev. Stat. § 439B.650 (2026).

Text

On or before June 1 of each year, the Department shall: 1. Analyze the information submitted pursuant to NRS 439B.635 to 439B.645 , inclusive, and compile a report on the price of prescription drugs. The report:

(a)Must include, without limitation, a separate analysis of the information reported by manufacturers, pharmacy benefit managers and wholesalers, the reasons for any increases in the prices of prescription drugs in this State and the effect of those prices on overall spending on prescription drugs, insurance premiums and cost-sharing in this State; and

(b)May include, without limitation, opportunities for persons and entities in this State to lower the cost of prescription drugs while maintaining access to such drugs. 2. Present the findings in the report at a public hearing.

Free access — add to your briefcase to read the full text and ask questions with AI

On or before June 1 of each year, the Department shall:
1. Analyze the information submitted pursuant to NRS 439B.635 to 439B.645 , inclusive, and compile a report on the price of prescription drugs. The report:
(a) Must include, without limitation, a separate analysis of the information reported by manufacturers, pharmacy benefit managers and wholesalers, the reasons for any increases in the prices of prescription drugs in this State and the effect of those prices on overall spending on prescription drugs, insurance premiums and cost-sharing in this State; and
(b) May include, without limitation, opportunities for persons and entities in this State to lower the cost of prescription drugs while maintaining access to such drugs.
2. Present the findings in the report at a public hearing.